Comparative effectiveness research

Scholarly Publications

Evaluating Human Papillomavirus Vaccination Programs

November 2004

Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials.

Can Technology Assessment Control Health Spending?

December 1994

Because medical technology is the most important controllable component of health spending growth, the success of strategies for limiting spending growth depends upon their impact on technology...

Cost-Effectiveness Analysis as a Measure of Value

December 1996

Other Publications

Interpretation of Cost-Effectiveness Analyses

December 1998

Cost-Effectiveness of Positron Emission Tomography for Diagnosis of Solitary Pulmonary Nodules

December 2001

Background: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) is a potentially useful but expensive test to diagnose solitary pulmonary nodules.Objective: To evaluate the cost...

News

Government's new HIV screening guidelines influenced by CHP/PCOR research

October 2006

The federal Centers for Disease Control and Prevention recently announced new guidelines recommending that all Americans ages 13 to 64 be voluntarily screened for HIV infection.

Treating men at high risk for HIV makes economic sense, says Stanford study

April 2012

Eran Bendavid says the results of his work are a departure from a previous study.

Copayments appear tied to antimicrobial resistance

July 2015

The increasing resistance to antimicrobial drugs is a growing public health concern, particularly in low- and middle-income countries that require high out-of-pocket payments for prescription drugs.